WVE Wave Life Sciences, Inc.
Nasdaq · SEC CIK 1631574 · EDGAR
- Bought, last 12 months
- $82.56M 3 purchases by 2 insiders
- Sold, last 12 months
- $16.18M 19 sales by 11 insiders
- Filings on record
- 123 since 2021-08-18, latest 2026-08-13 21:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | $54.63M | — |
| GSK plc | 10% | $27.93M | — |
| Francis Chris | See Remarks | — | $7.10M |
| Moran Kyle | CFO | — | $4.15M |
| Tan Aik Na | Dir | — | $1.83M |
| HENRY CHRISTIAN O | Dir | — | $1.37M |
| Rawcliffe Adrian | Dir | — | $806.6K |
| Verdine Gregory L. | Dir | — | $269.5K |
| Wagner Heidi L | Dir | — | $231.1K |
| CORRIGAN MARK | Dir | — | $217.3K |
Transactions 109
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-08-13 21:00 | 2026-08-11 | WVE | Wagner Heidi L | Dir | M - OptEx | $5.97 | +7,000 | 51.9K | +16% | +$41.8K |
| DT | 2026-08-13 21:00 | 2026-08-11 | WVE | Wagner Heidi L | Dir | S - Sale+OE | $6.01 | -7,000 | 44.9K | -13% | -$42.1K |
| T | 2026-08-13 21:00 | 2026-08-12 | WVE | Rawcliffe Adrian | Dir | S - Sale | $5.29 | -12.7K | 0 | -100% | -$67.2K |
| T | 2026-08-13 21:00 | 2026-08-11 | WVE | TAKANASHI KEN | Dir | S - Sale | $6.01 | -3,864 | 20.1K | -16% | -$23.2K |
| T | 2026-08-13 21:00 | 2026-08-11 | WVE | Tan Aik Na | Dir | S - Sale | $6.01 | -432 | 25.0K | -2% | -$2,596 |
| MI | 2026-03-30 | 2026-03-26+ | WVE | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | P - Purchase | $6.23 | +8.77M | 23.16M | +61% | +$54.62M |
| DI | 2026-03-26 | 2026-03-23 | WVE | TAKANASHI KEN | Dir | C - Cnv Deriv | $0.00 | +3.90M | 9.61M | +68% | $0 |
| DMT | 2026-02-27 | 2026-02-26 | WVE | Francis Chris | See Remarks | M - OptEx | $4.28 | +33.2K | 77.2K | +75% | +$141.9K |
| DMT | 2026-02-27 | 2026-02-26 | WVE | Francis Chris | See Remarks | S - Sale+OE | $15.05 | -33.2K | 61.9K | -35% | -$499.5K |
| D | 2026-02-11 | 2026-02-05 | WVE | Francis Chris | See Remarks | A - Grant | $0.00 | +38.8K | 63.8K | +155% | $0 |
| D | 2026-02-11 | 2026-02-09 | WVE | Francis Chris | See Remarks | S - Sale | $13.45 | -1,883 | 61.9K | -3% | -$25.3K |
| D | 2026-02-11 | 2026-02-09 | WVE | Vargeese Chandra | See Remarks | S - Sale | $13.45 | -3,228 | 408.2K | -0.8% | -$43.4K |
| D | 2026-02-11 | 2026-02-05 | WVE | Vargeese Chandra | See Remarks | A - Grant | $0.00 | +45.6K | 411.5K | +12% | $0 |
| D | 2026-02-11 | 2026-02-05 | WVE | Moran Kyle | CFO | A - Grant | $0.00 | +45.6K | 138.0K | +49% | $0 |
| D | 2026-02-11 | 2026-02-09 | WVE | Moran Kyle | CFO | S - Sale | $13.45 | -3,588 | 134.4K | -3% | -$48.3K |
| D | 2026-02-11 | 2026-02-09 | WVE | BOLNO PAUL | Pres, CEO, Dir | S - Sale | $13.45 | -10.5K | 275.5K | -4% | -$141.0K |
| D | 2026-02-11 | 2026-02-05 | WVE | BOLNO PAUL | Pres, CEO, Dir | A - Grant | $0.00 | +165.0K | 286.0K | +136% | $0 |
| DMT | 2026-01-06 | 2026-01-02 | WVE | Francis Chris | See Remarks | S - Sale+OE | $16.03 | -9,375 | 26.3K | -26% | -$150.3K |
| DT | 2026-01-06 | 2026-01-02 | WVE | Francis Chris | See Remarks | M - OptEx | $3.14 | +9,375 | 34.4K | +38% | +$29.4K |
| I | 2025-12-15 | 2025-12-11 | WVE | GSK plc | 10% | P - Purchase | $19.00 | +1.47M | 18.25M | +9% | +$27.93M |
| MT | 2025-12-10 | 2025-12-08 | WVE | Verdine Gregory L. | Dir | S - Sale | $13.47 | -20.0K | 275.2K | -7% | -$269.5K |
| DMT | 2025-12-10 | 2025-12-08 | WVE | HENRY CHRISTIAN O | Dir | M - OptEx | $5.07 | +87.0K | 42.7K | New | +$440.9K |
| DMT | 2025-12-10 | 2025-12-08 | WVE | HENRY CHRISTIAN O | Dir | S - Sale+OE | $14.65 | -93.4K | 12.7K | -88% | -$1.37M |
| DMT | 2025-12-10 | 2025-12-08 | WVE | Wagner Heidi L | Dir | M - OptEx | $5.97 | +14.0K | 51.9K | +37% | +$83.6K |
| DMT | 2025-12-10 | 2025-12-08 | WVE | Wagner Heidi L | Dir | S - Sale+OE | $13.50 | -14.0K | 44.9K | -24% | -$189.0K |
| DMT | 2025-12-10 | 2025-12-08 | WVE | Tan Aik Na | Dir | S - Sale+OE | $13.58 | -134.2K | 25.4K | -84% | -$1.82M |
| DMT | 2025-12-10 | 2025-12-08 | WVE | Tan Aik Na | Dir | M - OptEx | $4.85 | +119.2K | 57.6K | New | +$578.5K |
| DT | 2025-12-10 | 2025-12-08 | WVE | Rawcliffe Adrian | Dir | S - Sale+OE | $15.00 | -42.0K | 12.7K | -77% | -$630.0K |
| DT | 2025-12-10 | 2025-12-08 | WVE | Rawcliffe Adrian | Dir | M - OptEx | $5.97 | +42.0K | 54.7K | +331% | +$250.7K |
| MT | 2025-12-10 | 2025-12-08 | WVE | CORRIGAN MARK | Dir | S - Sale | $13.49 | -16.1K | 28.8K | -36% | -$217.3K |
| DMT | 2025-12-10 | 2025-12-08 | WVE | Francis Chris | See Remarks | S - Sale+OE | $14.58 | -441.0K | 25.0K | -95% | -$6.43M |
| DMT | 2025-12-10 | 2025-12-08 | WVE | Francis Chris | See Remarks | M - OptEx | $4.78 | +441.0K | 47.5K | New | +$2.11M |
| DMT | 2025-12-10 | 2025-12-08+ | WVE | Moran Kyle | CFO | M - OptEx | $5.20 | +296.0K | 189.2K | New | +$1.54M |
| DMT | 2025-12-10 | 2025-12-08+ | WVE | Moran Kyle | CFO | S - Sale+OE | $15.78 | -260.0K | 89.2K | -74% | -$4.10M |
| I | 2025-11-14 | 2025-11-13 | WVE | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | P - Purchase | $6.69 | +1,000 | 18.20M | +0.0% | +$6,690 |
| T | 2025-11-14 | 2025-11-13 | WVE | Rawcliffe Adrian | Dir | S - Sale | $6.79 | -16.1K | 12.7K | -56% | -$109.4K |
| T | 2025-08-26 | 2025-08-22 | WVE | Verdine Gregory L. | Dir | S - Sale | $10.00 | -10.0K | 285.2K | -3% | -$100.0K |
| T | 2025-08-26 | 2025-08-22 | WVE | BOLNO PAUL | Pres, CEO, Dir | S - Sale | $10.10 | -217.4K | 121.0K | -64% | -$2.20M |
| DT | 2025-08-19 | 2025-08-15 | WVE | Tan Aik Na | Dir | S - Sale+OE | $9.25 | -21.0K | 40.4K | -34% | -$194.2K |
| DT | 2025-08-19 | 2025-08-15 | WVE | Tan Aik Na | Dir | M - OptEx | $9.13 | +21.0K | 61.4K | +52% | +$191.7K |
| D | 2025-08-13 | 2025-08-11 | WVE | Rawcliffe Adrian | Dir | A - Grant | $0.00 | +12.7K | 28.8K | +79% | $0 |
| D | 2025-08-13 | 2025-08-11 | WVE | TAKANASHI KEN | Dir | A - Grant | $0.00 | +12.7K | 5.73M | +0.2% | $0 |
| DT | 2025-08-13 | 2025-08-11 | WVE | HENRY CHRISTIAN O | Dir | A - Grant | $0.00 | +12.7K | 39.3K | +48% | $0 |
| DT | 2025-08-13 | 2025-08-13 | WVE | HENRY CHRISTIAN O | Dir | S - Sale | $8.81 | -9,670 | 29.6K | -25% | -$85.2K |
| DI | 2025-08-13 | 2025-08-11 | WVE | RA Capital Healthcare Fund LP | Dir, 10% | A - Grant | $0.00 | +12.7K | 28.8K | +79% | $0 |
| D | 2025-08-13 | 2025-08-11 | WVE | CORRIGAN MARK | Dir | A - Grant | $0.00 | +12.7K | 44.9K | +39% | $0 |
| D | 2025-08-13 | 2025-08-11 | WVE | Tan Aik Na | Dir | A - Grant | $0.00 | +25.4K | 40.4K | +169% | $0 |
| D | 2025-08-13 | 2025-08-11 | WVE | Verdine Gregory L. | Dir | A - Grant | $0.00 | +12.7K | 295.2K | +4% | $0 |
| D | 2025-08-13 | 2025-08-11 | WVE | Wagner Heidi L | Dir | A - Grant | $0.00 | +12.7K | 44.9K | +39% | $0 |
| T | 2025-08-07 | 2025-08-05 | WVE | TAKANASHI KEN | Dir | S - Sale | $8.75 | -4,872 | 5.72M | -0.1% | -$42.6K |
| T | 2025-08-07 | 2025-08-05 | WVE | Tan Aik Na | Dir | S - Sale | $8.75 | -1,127 | 15.0K | -7% | -$9,861 |
| T | 2025-06-13 | 2025-06-13 | WVE | Verdine Gregory L. | Dir | S - Sale | $6.95 | -30.0K | 282.5K | -10% | -$208.5K |
| DT | 2025-03-21 | 2025-03-20 | WVE | HENRY CHRISTIAN O | Dir | S - Sale+OE | $9.77 | -10.5K | 16.1K | -39% | -$102.6K |
| DT | 2025-03-21 | 2025-03-20 | WVE | HENRY CHRISTIAN O | Dir | M - OptEx | $9.13 | +10.5K | 26.6K | +65% | +$95.9K |
| DT | 2025-03-07 | 2025-03-07 | WVE | BOLNO PAUL | Pres, CEO, Dir | S - Sale+OE | $9.57 | -169.0K | 338.4K | -33% | -$1.62M |
| DT | 2025-03-07 | 2025-03-07 | WVE | BOLNO PAUL | Pres, CEO, Dir | M - OptEx | $2.48 | +169.0K | 507.4K | +50% | +$419.2K |
| DM | 2025-03-07 | 2025-03-05+ | WVE | Verdine Gregory L. | Dir | M - OptEx | $2.48 | +266.4K | 179.2K | New | +$660.7K |
| D | 2025-03-05 | 2025-03-04 | WVE | Vargeese Chandra | See Remarks | M - OptEx | $2.48 | +91.8K | 362.7K | +34% | +$227.5K |
| D | 2025-02-06 | 2025-02-04 | WVE | Vargeese Chandra | See Remarks | A - Grant | $0.00 | +37.0K | 270.9K | +16% | $0 |
| D | 2025-02-06 | 2025-02-04 | WVE | Moran Kyle | CFO | A - Grant | $0.00 | +42.0K | 89.2K | +89% | $0 |
| D | 2025-02-06 | 2025-02-04 | WVE | BOLNO PAUL | Pres, CEO, Dir | A - Grant | $0.00 | +121.0K | 338.4K | +56% | $0 |
| D | 2025-02-06 | 2025-02-04 | WVE | Francis Chris | See Remarks | A - Grant | $0.00 | +25.0K | 25.0K | New | $0 |
| D | 2025-01-24 | 2025-01-23 | WVE | Vargeese Chandra | See Remarks | M - OptEx | $2.48 | +46.0K | 233.9K | +24% | +$114.1K |
| DT | 2024-11-27 | 2024-11-25 | WVE | BOLNO PAUL | Pres, CEO, Dir | S - Sale+OE | $15.00 | -50.0K | 217.4K | -19% | -$750.0K |
| DT | 2024-11-27 | 2024-11-25 | WVE | BOLNO PAUL | Pres, CEO, Dir | M - OptEx | $2.48 | +50.0K | 267.4K | +23% | +$124.0K |
| T | 2024-11-15 | 2024-11-15 | WVE | BOLNO PAUL | Pres, CEO, Dir | S - Sale | $14.32 | -51.2K | 217.4K | -19% | -$733.7K |
| DT | 2024-11-13 | 2024-11-08 | WVE | Francis Chris | See Remarks | S - Sale+OE | $16.00 | -36.0K | 0 | -100% | -$576.0K |
| DT | 2024-11-13 | 2024-11-08 | WVE | Francis Chris | See Remarks | M - OptEx | $8.17 | +36.0K | 36.0K | New | +$294.1K |
| T | 2024-10-18 | 2024-10-16 | WVE | BOLNO PAUL | Pres, CEO, Dir | S - Sale | $15.00 | -90.5K | 268.6K | -25% | -$1.36M |
| DMT | 2024-10-18 | 2024-10-16 | WVE | Francis Chris | See Remarks | M - OptEx | $2.88 | +129.1K | 22.5K | New | +$371.4K |
| DMT | 2024-10-18 | 2024-10-16 | WVE | Francis Chris | See Remarks | S - Sale+OE | $13.67 | -208.8K | 0 | -100% | -$2.86M |
| D | 2024-10-11 | 2024-10-11 | WVE | Moran Kyle | CFO | M - OptEx | $2.48 | +25.0K | 44.8K | +126% | +$62.0K |
| I | 2024-10-01 | 2024-09-27 | WVE | GSK plc | 10% | P - Purchase | $8.00 | +2.79M | 16.78M | +20% | +$22.34M |
| T | 2024-09-27 | 2024-09-25 | WVE | Moran Kyle | CFO | S - Sale | $9.00 | -17.1K | 19.8K | -46% | -$154.3K |
| T | 2024-08-23 | 2024-08-21 | WVE | BOLNO PAUL | Pres, CEO, Dir | S - Sale | $5.78 | -48.4K | 359.1K | -12% | -$279.6K |
| D | 2024-08-14 | 2024-08-12 | WVE | CORRIGAN MARK | Dir | A - Grant | $0.00 | +32.2K | 32.2K | New | $0 |
| DI | 2024-08-14 | 2024-08-12 | WVE | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | A - Grant | $0.00 | +16.1K | 16.1K | New | $0 |
| D | 2024-08-14 | 2024-08-12 | WVE | HENRY CHRISTIAN O | Dir | A - Grant | $0.00 | +16.1K | 16.1K | New | $0 |
| D | 2024-08-14 | 2024-08-12 | WVE | TAKANASHI KEN | Dir, 10% | A - Grant | $0.00 | +16.1K | 5.72M | +0.3% | $0 |
| D | 2024-08-14 | 2024-08-12 | WVE | Tan Aik Na | Dir | A - Grant | $0.00 | +16.1K | 16.1K | New | $0 |
| D | 2024-08-14 | 2024-08-12 | WVE | Wagner Heidi L | Dir | A - Grant | $0.00 | +32.2K | 32.2K | New | $0 |
| D | 2024-08-14 | 2024-08-12 | WVE | Verdine Gregory L. | Dir | A - Grant | $0.00 | +16.1K | 46.1K | +54% | $0 |
| D | 2024-08-14 | 2024-08-12 | WVE | Rawcliffe Adrian | Dir | A - Grant | $0.00 | +16.1K | 16.1K | New | $0 |
| D | 2024-07-24 | 2024-07-22 | WVE | Vargeese Chandra | See Remarks | M - OptEx | $2.48 | +68.2K | 185.1K | +58% | +$169.2K |
| T | 2024-04-05 | 2024-04-03 | WVE | Moran Kyle | CFO | S - Sale | $6.17 | -15.6K | 33.9K | -32% | -$96.4K |
| I | 2024-01-30 | 2023-12-07 | WVE | GSK plc | 10% | P - Purchase | $5.00 | +3.30M | 13.98M | +31% | +$16.50M |
| AI | 2024-01-17 | 2023-12-11 | WVE | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | P - Purchase | $5.00 | +1.00M | 18.20M | +6% | +$5.00M |
| I | 2023-12-13 | 2023-12-11 | WVE | Kolchinsky Peter | Dir, 10% | P - Purchase | $5.00 | +1.00M | 19.20M | +5% | +$5.00M |
| 2023-08-23 | 2023-08-23 | WVE | Moran Kyle | CFO | S - Sale | $4.75 | -37.1K | 46.1K | -45% | -$176.0K | |
| D | 2023-02-17 | 2023-02-16 | WVE | Vargeese Chandra | See Remarks | S - Sale | $4.03 | -10.2K | 106.6K | -9% | -$41.3K |
| D | 2023-02-17 | 2023-02-16 | WVE | Francis Chris | See Remarks | S - Sale | $4.03 | -10.3K | 79.7K | -11% | -$41.3K |
| D | 2023-02-17 | 2023-02-16 | WVE | BOLNO PAUL | Pres, CEO, Dir | S - Sale | $4.04 | -29.4K | 407.4K | -7% | -$118.8K |
| D | 2023-02-17 | 2023-02-16 | WVE | Moran Kyle | CFO | S - Sale | $4.04 | -9,729 | 79.8K | -11% | -$39.3K |
| DI | 2022-06-21 | 2022-06-16 | WVE | RA Capital Healthcare Fund LP | Dir, 10% | P - Purchase | $2.15 | +9.48M | 17.20M | +123% | +$20.38M |
| 2022-05-06 | 2022-05-04 | WVE | Vargeese Chandra | See Remarks | A - Grant | $0.00 | +50.0K | 127.8K | +64% | $0 | |
| 2022-05-06 | 2022-05-05 | WVE | Vargeese Chandra | See Remarks | S - Sale | $1.72 | -16.7K | 111.1K | -13% | -$28.7K | |
| 2022-05-06 | 2022-05-05 | WVE | Panzara Michael A. | See Remarks | S - Sale | $1.72 | -16.7K | 109.1K | -13% | -$28.7K | |
| 2022-05-06 | 2022-05-04 | WVE | Panzara Michael A. | See Remarks | A - Grant | $0.00 | +50.0K | 125.8K | +66% | $0 | |
| 2022-05-06 | 2022-05-05 | WVE | Francis Chris | See Remarks | S - Sale | $1.72 | -10.9K | 90.0K | -11% | -$18.7K | |
| 2022-05-06 | 2022-05-04 | WVE | Francis Chris | See Remarks | A - Grant | $0.00 | +32.5K | 100.8K | +48% | $0 |
Purchase Sale Sale after option exercise All abbreviations